We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRT
2951
DELISTED
Startek Inc.
SRT
$138K ﹤0.01%
19,321
-3,285
-15% -$24.2K
SEEL
2952
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$137K ﹤0.01%
+14
New +$230K
REV
2953
DELISTED
Revlon, Inc.
REV
$136K ﹤0.01%
10,622
-1,536
-13% -$19.3K
NGVC icon
2954
Vitamin Cottage Natural Grocers
NGVC
$748M
$135K ﹤0.01%
12,604
+403
+3% +$5.46K
PBFS icon
2955
Pioneer Bancorp
PBFS
$433M
$133K ﹤0.01%
11,098
-1,780
-14% -$21.3K
FORA
2956
DELISTED
Forian
FORA
$129K ﹤0.01%
+10,258
New +$117K
MBII
2957
DELISTED
Marrone Bio Innovations, Inc.
MBII
$128K ﹤0.01%
77,274
+2,132
+3% +$3.56K
IRON icon
2958
Disc Medicine
IRON
$2.97B
$125K ﹤0.01%
+646
New +$212K
HOOK
2959
DELISTED
HOOKIPA Pharma
HOOK
$123K ﹤0.01%
+1,339
New +$179K
CLPR
2960
Clipper Realty
CLPR
$45.2M
$118K ﹤0.01%
16,013
-3,897
-20% -$31.6K
CTOS icon
2961
Custom Truck One Source
CTOS
$2.52B
$116K ﹤0.01%
12,145
-3,214
-21% -$31.6K
OTLK icon
2962
Outlook Therapeutics
OTLK
$182M
$115K ﹤0.01%
+2,299
New +$107K
PSEC icon
2963
Prospect Capital
PSEC
$1.11B
$113K ﹤0.01%
13,526
-292
-2% -$2.44K
STKS icon
2964
The ONE Group
STKS
$54.3M
$113K ﹤0.01%
+10,215
New +$104K
ARKO icon
2965
ARKO Corp
ARKO
$818M
$111K ﹤0.01%
+12,131
New +$123K
ADN
2966
DELISTED
Advent Technologies
ADN
$109K ﹤0.01%
+377
New +$125K
ATCX
2967
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$109K ﹤0.01%
+11,297
New +$119K
PPTA
2968
Perpetua Resources
PPTA
$2.86B
$107K ﹤0.01%
+14,704
New +$115K
TH icon
2969
Target Hospitality
TH
$1.59B
$97K ﹤0.01%
26,184
-18,068
-41% -$59.8K
SMMT icon
2970
Summit Therapeutics
SMMT
$10.8B
$93K ﹤0.01%
+12,518
New +$82.1K
NL icon
2971
NLI Holdings
NL
$308M
$81K ﹤0.01%
12,501
-1,784
-12% -$13.2K
KLDO
2972
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$81K ﹤0.01%
+10,842
New +$76.8K
RIG icon
2973
Transocean
RIG
$5.71B
$74K ﹤0.01%
16,307
-929,485
-98% -$3.53M
STON
2974
DELISTED
StoneMor Inc.
STON
$53K ﹤0.01%
+20,220
New +$46K
PLM
2975
DELISTED
PolyMet Mining Corp.
PLM
$51K ﹤0.01%
+14,214
New +$44.7K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.